First, although the in vitro cell line experiments and CNA analyses using TCGA data clearly demonstrated the effects of STIL overexpression in NSCLC, these findings have not been confirmed in primary NSCLC tissues of our own or patient-derived models. This evidence concerns the gene STIL and non-small cell lung carcinoma.